ICON Announces CFO Transition
03 Abril 2024 - 5:15PM
Business Wire
ICON plc (NASDAQ: ICLR), a world-leading
healthcare intelligence and clinical research organization, today
announced that Chief Financial Officer, Brendan Brennan, will leave
his role at ICON in quarter four this year for a new opportunity
outside of the CRO industry. Brendan has held the role since 2012
and will remain with the company in his current role as CFO to
ensure a smooth transition to a newly appointed Chief Financial
Officer. ICON has commenced a search to identify the next CFO.
“On behalf of the ICON Board and Leadership Team, I want to
thank Brendan for his strong contributions to ICON over his 18
years, including 12 years as CFO,” said Steve Cutler, ICON’s CEO.
“His effective leadership has contributed significantly to the
growth of the company over an extended period and we wish him well
with this new opportunity. We have commenced a search to identify
our next CFO and will update on that process at the appropriate
time. In the meantime, Brendan will continue to lead the ICON
finance team as CFO.”
“It has been both a privilege and a pleasure to serve as ICON’s
CFO for the last 12 years,” said Chief Financial Officer, Brendan
Brennan. “With ICON’s market leading position, having successfully
integrated PRA Health Sciences, and having been with ICON for 18
years, personally it feels like the right time for me to take on a
new challenge in a new industry. I am proud of, and grateful for,
my long tenure with ICON and believe the company is well positioned
for future growth and success.”
The company also reaffirmed its previously announced full year
2024 guidance. ICON expects full year 2024 revenue to be in the
range of $8,400 - $8,800 million, representing a year over year
increase of 3.4% to 8.4%, and adjusted earnings per share in the
range of $14.50 - $15.30, representing a year over year increase of
13.4% to 19.6%. Adjusted earnings per share to exclude
amortization, stock compensation, restructuring, foreign exchange
and transaction-related / integrated-related adjustments. The
company will report first quarter 2024 results on Wednesday, April
24 after the market closes, and will hold its first quarter 2024
earnings conference call on Thursday, April 25 at 8am Eastern
Time.
About ICON plc
ICON plc is a world-leading healthcare intelligence and clinical
research organization. From molecule to medicine, we advance
clinical research providing outsourced services to pharmaceutical,
biotechnology, medical device and government and public health
organizations. We develop new innovations, drive emerging therapies
forward and improve patient lives. With headquarters in Dublin,
Ireland, ICON employed approximately 41,100 employees in 106
locations in 53 countries as at December 31, 2023. For further
information about ICON, visit: www.iconplc.com.
This press release contains forward-looking statements,
including statements about our financial guidance. These statements
are based on management's current expectations and information
currently available, including current economic and industry
conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
integration of new business mergers and acquisitions, as well as
other economic and global market conditions and other risks and
uncertainties detailed from time to time in SEC reports filed by
ICON, all of which are difficult to predict and some of which are
beyond our control. For these reasons, you should not place undue
reliance on these forward-looking statements when making investment
decisions. The word "expected" and variations of such words and
similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they
are made and we do not undertake any obligation to update publicly
any forward-looking statement, either as a result of new
information, future events or otherwise. More information about the
risks and uncertainties relating to these forward-looking
statements may be found in SEC reports filed by ICON, including its
Form 20-F, F-1, F-4, S-8, F-3 and certain other reports, which are
available on the SEC's website at http://www.sec.gov.
ICON/ICLR-F
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240403248673/en/
Kate Haven Vice President Investor Relations +1 888 381 7923
ICON (NASDAQ:ICLR)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025
ICON (NASDAQ:ICLR)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025